<bill session="116" type="h" number="3520" updated="2022-11-01T13:50:52Z">
  <state datetime="2019-06-26">REFERRED</state>
  <status>
    <introduced datetime="2019-06-26"/>
  </status>
  <introduced datetime="2019-06-26"/>
  <titles>
    <title type="display">Stem Cell Therapeutic and Research Reauthorization Act of 2019</title>
    <title type="official" as="introduced">To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.</title>
    <title type="short" as="introduced">Stem Cell Therapeutic and Research Reauthorization Act of 2019</title>
  </titles>
  <sponsor bioguide_id="S000522"/>
  <cosponsors>
    <cosponsor bioguide_id="A000378" joined="2019-08-02"/>
    <cosponsor bioguide_id="B001257" joined="2019-06-26"/>
    <cosponsor bioguide_id="L000569" joined="2019-09-17"/>
  </cosponsors>
  <actions>
    <action datetime="2019-06-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-06-26" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-06-27">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="4764" relation="unknown"/>
    <bill session="116" type="s" number="4672" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Blood and blood diseases"/>
    <term name="Cell biology and embryology"/>
    <term name="Health programs administration and funding"/>
    <term name="Medical research"/>
    <term name="Organ and tissue donation and transplantation"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2020-12-15T16:44:31Z" status="Introduced in House">Stem Cell Therapeutic and Research Reauthorization Act of 2019 This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood.

The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.</summary>
</bill>
